Regeneron, Eli Lilly antibody treatments should no longer be used, FDA says
U.S. health officials say COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant.The Food and Drug Administration said Monday it is revoking…